We are WELLLIFEMED Corporation
We are a global healthcare company dedicated to the design, manufacture and distribution of high-quality medical supply.
WelllifeMed Co., Ltd. is a specialized manufacturer of medical devices, mainly producing pen needles, which are the core base of diabetics.
WellLifeMed has developed a line of breakthrough healthcare products infusing high-quality safety with cutting-edge diabetes technology.
We combine cutting edge medical science with dedicated healthcare mastery to push the limits of injection quality and treatment.

Because we believe your health and well-being.
So we prescribe a care system tailored to its specific customer needs putting performance first.

At WellLifeMed, We are committed to continuous product innovation and for customer satisfaction, excellence in the best medical supply based product development, and professional healthcare commitment and diabetic management.
Thanks for your attention.
History of WelllifeMed
2001. 07. Established DAEJIN INDUSTRIAL
2001. 08. First domestic customer deliver
2002. 06. First export transition JENSEN GLOBAL
2003. 01. Sales exceeded KRW 300 million
2005. 05. Acquired industrial needle patent
2006. 12. Sales exceeded KRW 500 million
2007. 05. Signed a strategic partnership (SHINA CORPORATION)
2008. 06. Exceeded $100,000 in exports
2009. 11. Sale exceeded KRW 900 million
2013. 07. Converted to SHINAINDUS CO., LTD.
2020. 12. Obtain medical device manufacturing permission by KFDA
2021. 02. Changed company name to W.L. MED CO., LTD.
2021. 05. ISO 13485
2021. 06. Certified GMP (Good Manufacturing Practice)
Obtained manufacturing permission of insulin Pen Needle
2022. 05. Approved FDA 510K
WelllifeMed's Certificate